Related Articles
Treatment of acute myeloid leukemia with active pulmonary tuberculosis with venetoclax‑based anti‑acute myeloid leukemia regimen combined with an intensive and then individualized anti‑tuberculosis regimen: A report of two cases
Cytotoxic effect of CLL‑1 CAR‑T cell immunotherapy with PD‑1 silencing on relapsed/refractory acute myeloid leukemia
CD14+HLA-DRlow/‑ expression: A novel prognostic factor in chronic lymphocytic leukemia
Meta‑analysis of the efficacy of venetoclax and azacitidine combination therapy and azacitidine monotherapy for treating acute myeloid leukemia
In vivo, <em>ex vivo</em> and <em>in vitro</em> dasatinib activity in chronic lymphocytic leukemia